Search hospitals > Minnesota > Burnsville
M Health Fairview Ridges Hospital
Claim this profileBurnsville, Minnesota 55337
Conducts research for Stroke
Conducts research for Coronavirus
Conducts research for Ischemic Stroke
Conducts research for COVID-19
Conducts research for Respiratory Distress Syndrome
4 reported clinical trials
1 medical researcher
Summary
M Health Fairview Ridges Hospital is a medical facility located in Burnsville, Minnesota. This center is recognized for care of Stroke, Coronavirus, Ischemic Stroke, COVID-19, Respiratory Distress Syndrome and other specialties. M Health Fairview Ridges Hospital is involved with conducting 4 clinical trials across 12 conditions. There are 1 research doctors associated with this hospital, such as Christopher Streib, MD.Top PIs
Clinical Trials running at M Health Fairview Ridges Hospital
Stroke
Ischemic Stroke
Milvexian
for Stroke
This trial is testing whether milvexian can help prevent another stroke in people who have already had one by stopping blood clots from forming. Milvexian may reduce the risk of stroke without significant bleeding.
Recruiting1 award Phase 35 criteria
Recombinant Factor VIIa
for Hemorrhagic Stroke
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 180 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy. FASTEST Part 2 is an extension of the FASTEST Trial where the subgroups include only those treated within 2 hours with a positive spot sign on a baseline CT angiogram.
Recruiting1 award Phase 32 criteria
rFVIIa
for Hemorrhagic Stroke
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 180 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at M Health Fairview Ridges Hospital?
M Health Fairview Ridges Hospital is a medical facility located in Burnsville, Minnesota. This center is recognized for care of Stroke, Coronavirus, Ischemic Stroke, COVID-19, Respiratory Distress Syndrome and other specialties. M Health Fairview Ridges Hospital is involved with conducting 4 clinical trials across 12 conditions. There are 1 research doctors associated with this hospital, such as Christopher Streib, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.